Novavax Inc (NVAX)
8.90
+4.42
(+98.66%)
USD |
NASDAQ |
May 10, 16:00
8.92
+0.02
(+0.22%)
After-Hours: 18:50
Novavax 1 Year Total Returns (Daily): -52.94% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 09, 2024 | -52.94% |
May 08, 2024 | -40.00% |
May 07, 2024 | -40.21% |
May 06, 2024 | -38.26% |
May 03, 2024 | -31.05% |
May 02, 2024 | -33.10% |
May 01, 2024 | -39.51% |
April 30, 2024 | -43.55% |
April 29, 2024 | -44.07% |
April 26, 2024 | -45.68% |
April 25, 2024 | -48.23% |
April 24, 2024 | -48.64% |
April 23, 2024 | -51.73% |
April 22, 2024 | -53.11% |
April 19, 2024 | -55.69% |
April 18, 2024 | -58.17% |
April 17, 2024 | -58.88% |
April 16, 2024 | -56.44% |
April 15, 2024 | -55.02% |
April 12, 2024 | -52.65% |
April 11, 2024 | -52.43% |
April 10, 2024 | -46.75% |
April 09, 2024 | -47.75% |
April 08, 2024 | -47.64% |
April 05, 2024 | -41.77% |
Date | Value |
---|---|
April 04, 2024 | -39.51% |
April 03, 2024 | -38.65% |
April 02, 2024 | -34.63% |
April 01, 2024 | -32.90% |
March 28, 2024 | -22.40% |
March 27, 2024 | -20.36% |
March 26, 2024 | -22.02% |
March 25, 2024 | -20.36% |
March 22, 2024 | -18.69% |
March 21, 2024 | -21.59% |
March 20, 2024 | -19.23% |
March 19, 2024 | -16.97% |
March 18, 2024 | -13.61% |
March 15, 2024 | -10.34% |
March 14, 2024 | -20.57% |
March 13, 2024 | -23.36% |
March 12, 2024 | -22.39% |
March 11, 2024 | -21.32% |
March 08, 2024 | -20.90% |
March 07, 2024 | -19.51% |
March 06, 2024 | -23.05% |
March 05, 2024 | -27.57% |
March 04, 2024 | -28.61% |
March 01, 2024 | -21.43% |
February 29, 2024 | -46.65% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.25%
Minimum
Dec 19 2022
4.97K%
Maximum
Feb 08 2021
367.9%
Average
-64.39%
Median
Jul 11 2022
1 Year Total Returns (Daily) Benchmarks
Pfizer Inc | -21.79% |
Moderna Inc | -8.28% |
Agilent Technologies Inc | 14.79% |
Halozyme Therapeutics Inc | 43.43% |
Vaxart Inc | -15.79% |